Total Funding
70
79
Total FundingSeries E raised
Growth Score
1 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15535
Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Mike Payne: Head of Commercial and PolicyPast Role: Omada Health, CCO & Head of Medical Affairs- David Hatch: Vice President, Head of User Experience Design
About the Company
Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with
sustained improvements in blood pressure, inflammation, liver function, and BMI.
Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes.
Founded in 2014, the company is headquartered in San Francisco, California.
